LENZ
LENZ Therapeutics Inc.

1,212
Mkt Cap
$961.23M
Volume
42,443.00
52W High
$50.40
52W Low
$16.54
PE Ratio
-14.58
LENZ Fundamentals
Price
$30.82
Prev Close
$30.72
Open
$30.62
50D MA
$35.03
Beta
1.09
Avg. Volume
1.17M
EPS (Annual)
-$2.34
P/B
4.53
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3% - Here's What Happened
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6.3% - Time to Sell...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Moderate Buy" by Brokerages
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat reports...
MarketBeat·5d ago
News Placeholder
Zacks Research Downgrades LENZ Therapeutics (NASDAQ:LENZ) to Hold
Zacks Research cut LENZ Therapeutics from a "strong-buy" rating to a "hold" rating in a report on Thursday...
MarketBeat·5d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Insider Shawn Olsson Sells 10,000 Shares
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) insider Shawn Olsson sold 10,000 shares of LENZ Therapeutics stock in a transaction dated Monday, November 17th. The shares were sold at an...
MarketBeat·8d ago
News Placeholder
Candriam S.C.A. Takes $5.02 Million Position in LENZ Therapeutics, Inc. $LENZ
Candriam S.C.A. purchased a new position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·11d ago
News Placeholder
Calamos Advisors LLC Makes New $515,000 Investment in LENZ Therapeutics, Inc. $LENZ
Calamos Advisors LLC acquired a new stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange...
MarketBeat·12d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6% - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 6% - Here's What Happened...
MarketBeat·15d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Trading Up 11.5% After Insider Buying Activity
LENZ Therapeutics (NASDAQ:LENZ) Trading Up 11.5% on Insider Buying Activity...
MarketBeat·16d ago
News Placeholder
James Mccollum Acquires 10,500 Shares of LENZ Therapeutics (NASDAQ:LENZ) Stock
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) Director James Mccollum purchased 10,500 shares of LENZ Therapeutics stock in a transaction dated Friday, November 7th. The shares were...
MarketBeat·17d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Director Purchases $239,295.00 in Stock
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) Director James Mccollum bought 10,500 shares of LENZ Therapeutics stock in a transaction dated Friday, November 7th. The stock was purchased at...
MarketBeat·17d ago

Latest LENZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.